Epeleuton manufacturers
- Epeleuton
-
- $2500.00
-
2026-05-11
- CAS:1667760-39-5
- Purity:
- Supply Ability: 10g
|
| | Epeleuton Basic information |
| Product Name: | Epeleuton | | Synonyms: | Epeleuton;5,8,11,13,17-Eicosapentaenoic acid, 15-hydroxy-, ethyl ester, (5Z,8Z,11Z,13E,15S,17Z)- | | CAS: | 1667760-39-5 | | MF: | C22H34O3 | | MW: | 346.5 | | EINECS: | | | Product Categories: | | | Mol File: | 1667760-39-5.mol |  |
| | Epeleuton Chemical Properties |
| Boiling point | 460.2±45.0 °C(Predicted) | | density | 0.959±0.06 g/cm3(Predicted) | | pka | 13.97±0.20(Predicted) |
| | Epeleuton Usage And Synthesis |
| Uses | Epeleuton-d5 (15(S)-HEPE-d5 ethyl ester) is deuterium labeled Epeleuton. Epeleuton is a second-generation synthetic N-3 fatty acid derivative with activity in patients with non-alcoholic fatty liver disease, although it did not reach the primary endpoints of alanine aminotransferase and liver stiffness, but it can significantly reduce triglycerides, glycated hemoglobin, plasma glucose and inflammatory markers[1]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110
[2] Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers |
| | Epeleuton Preparation Products And Raw materials |
|